Report Code: A03916 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Fibrinogen is a soluble plasma glycoprotein with a molecular weight of about 340 kDa. Fibrinogen concentrate is specified for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. It is a glycoprotein in vertebrates used as a medicine for blood disease, which helps in the formation of blood clots. In severely bleeding patients, fibrinogen concentrate significantly improves whole blood clot firmness and reduces the postoperative transfusion requirements. It is a physiological substrate of three enzymes, thrombin, factor XIIIa, and plasmin. Currently, fibrinogen concentrates are widely used instead of traditional sources of fibrinogen, such as fresh frozen plasma and cryoprecipitate.
The factors such as increase in use of fibrinogen concentrates in bleeding patients and for the treatment of congenital deficiencies drive the growth of the global market. Moreover, rise in awareness and concerns pertaining to the health boots the growth of the market. However, certain adverse reactions such as arterial thrombosis, chills, dyspnea, nausea, vomiting, and pulmonary embolism restrain the growth.
The global fibrinogen concentrates market is segmented based on type, application, and geography. On the basis of type, the market is divided into human fibrinogen concentrates and animal fibrinogen concentrates. By application, it is categorized into congenital fibrinogen deficiency and surgical procedures. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players profiled in the report include CSL Behring, Baxter International Inc., LFB Group, ProFibrix BV, Shanghai RAAS, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical Co. Ltd., Green Cross International, and Shanghai Xinxing Medicine Co. Ltd.
Key Benefits
Fibrinogen Concentrates Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Application |
|
By Region |
|
Key Market Players | Shanghai RAAS, LFB Group, CSL Behring, Shanghai Xinxing Medicine Co. Ltd, Harbin Pacific Biopharmaceutical Co. Ltd., Green Cross International, Jiangxi Boya Bio Pharmaceutical, ProFibrix BV, Baxter International Inc., Hualan Biological Engineering |
Loading Table Of Content...
Start reading.
This Report and over 71,321+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers